{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=26907", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=26907", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=26907&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=26907", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=26907", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?uin=26907", "items" : [{"_about" : "http://data.parliament.uk/resources/1719051", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1719051/answer", "answerText" : {"_value" : "
The Department works with NHS England to raise awareness of cancers, including for people with increased risk of cancer. In January 2024, NHS England relaunched the Help Us Help You cancer awareness campaign, designed to increase earlier diagnosis by encouraging people to come forward with suspected signs of cancers.<\/p>
For individuals with neurofibromatosis type 1 (NF1), who are at increased risk of breast cancer, the National Health Service in England recommends breast screening from the age of 40 years old. It is important that awareness of this is widespread among patients and general practices (GPs). Treatment for NF1 involves regular monitoring, and if a patient develops complex problems, their GP can usually refer them to one of two specialist NHS centres, so that a treatment plan can be drawn up. These centres are at Guy\u2019s and St Thomas\u2019 in London, and at Manchester University Hospital.<\/p>
We expect clinicians to keep themselves appraised of developments within conditions, and to refer to the National Institute for Clinical Excellence guidance as part of their clinical decision-making process.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T08:05:03.843Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Neurofibromatosis: Breast Cancer"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps she has taken with NHS England to help raise awareness by (a) patients and (b) GPs of the increased risk of breast cancer in people with neurofibromatosis type 1.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4618", "label" : {"_value" : "Biography information for Liz Twist"} } , "tablingMemberConstituency" : {"_value" : "Blaydon"} , "tablingMemberPrinted" : [{"_value" : "Liz Twist"} ], "uin" : "26907"} , {"_about" : "http://data.parliament.uk/resources/1484272", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1484272/answer", "answerText" : {"_value" : "